This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Genmab A/S (GMAB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Genmab (NASDAQ:GMAB) with a Buy and

Company Announcement COPENHAGEN, Denmark; September 8, 2026 – Genmab A/S (Nasdaq: GMAB) will increas

Company Announcement Genmab A/S to hold an Extraordinary General Meeting on Wednesday, October 7, 20

Media Release COPENHAGEN, Denmark; August 25, 2026 Genmab A/S (Nasdaq: GMAB ) announced today that m

With all eyes locked on this morning's CPI release and the Strait of Hormuz nearly shut down, Wall S

Company Announcement COPENHAGEN, Denmark; August 11, 2026 – Genmab A/S (Nasdaq: GMAB) will increase

Guggenheim analyst Michael Schmidt maintains Genmab (NASDAQ:GMAB) with a Buy and raises the price

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

Genmab (NASDAQ:GMAB) raises FY2026 sales outlook from $4.065 billion-$4.395 billion to $4.325 billio

Genmab A/S NASDAQ: GMAB reported first-half 2026 revenue growth of 25% year over year and raised its

Avidity Partners Management LP reduced its stake in Genmab A/S Sponsored ADR (NASDAQ: GMAB) by 45.7%

Genmab's buy rating with a $36 12-month target implies roughly 25% upside from the $28.74 reference

COPENHAGEN, Denmark & NORTH CHICAGO, Ill.--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) and AbbVie (NY

Genmab has underperformed so far this year despite strong commercial performance and largely positiv

Wall Street lit up Tuesday with massive earnings beats and a crypto surge, but Wednesday morning fut

 Net trade sales were USD 2,435 million in the U.S. and USD 1,772 million in the rest of the world.

Company Announcement Net sales of DARZALEX ® in the second quarter of 2026 totaled USD 4,207 million

AbbVie's EU approval expands Tepkinly into a first-of-its-kind bispecific lymphoma combination, back

Media ReleaseCOPENHAGEN, Denmark; July 6, 2026 TEPKINLY (epcoritamab) plus lenalidomide and rituxima

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) announced today that the European Co

Wall Street analysts updated ratings and price targets for top companies, including Robinhood, Westl

Genmab A/S – ADR (NASDAQ:GMAB) on Monday shared topline results from the Phase 3 EPCORE DLBCL-4 tria

AVAV: 31% | AeroVironment shares are trading higher after the company reported better-than-expected

The Danish biotechnology company and partner AbbVie said a drug combination to treat lymphoma met th

Company Announcement Topline results from Phase 3 EPCORE ®  DLBCL-4 evaluating epcoritamab in combin

Corbus reports FDA alignment on the CRB-701 path, as analysts flag upside tied to the head and neck

https://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/october-december-2025-new-safety-

Wall Street analysts change outlook on top names. Check analyst ratings page for upgrades, downgrade

U.S. stock futures were higher this morning, with the Dow Jones futures gaining over 50 points on Tu

  On Friday, 68 companies reached new 52-week highs.

  During Monday's session, 50 stocks hit new 52-week highs.

  On Tuesday, 951 companies hit new 52-week lows.

  On Wednesday, 807 companies reached new 52-week lows.

Upgrades

    On Thursday morning, 159 companies achieved new highs for the year.

    During Tuesday's morning trading, 101 companies set new 52-week highs.

    On Friday morning, 154 companies achieved new highs for the year.

    On Friday morning, 126 companies achieved new highs for the year.

    Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.

  This morning 77 companies reached new 52-week highs.

  Wednesday morning saw 123 companies set new 52-week highs.

  During Thursday's morning session, 316 companies made new 52-week highs.

Full List: EYE, FIVN, BLDR, HUBS, GO, SNPS, NTLA, PCTY, TTEC, REZI, SI, GRBK, CARR, DRIV, IPHI, MELI

Tuesday morning saw 181 companies set new 52-week highs.

During Wednesday's morning session, 145 stocks hit new 52-week highs.